Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In Brest
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In Hefei
This study is recruiting in India and in Israel. It focuses on Depression.
Multiple locations, including AhmedabadThis study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting in the United States, in France, in Bulgaria, .... It is testing ACP-204 for Schizophrenia.
Multiple locations, including IrvineThis study is recruiting in the United Kingdom, in Argentina, in Brazil, .... It is testing lurasidone for schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In IndianapolisThis study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United Kingdom
This study is recruiting in Germany. It focuses on depression.
In GermanyHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.